From ce4432b9708b66c84a77d6bdcf10bf0278eee283 Mon Sep 17 00:00:00 2001
From: BMX <bmxlab@proton.me>
Date: Wed, 2 Sep 2026 07:34:11 +0000
Subject: [PATCH] Add Template.md

---
 Template.md | 48 ++++++++++++++++++++++++++++++++++++++++++++++++
 1 file changed, 48 insertions(+)
 create mode 100644 Template.md

diff --git a/Template.md b/Template.md
new file mode 100644
index 0000000..6433972
--- /dev/null
+++ b/Template.md
@@ -0,0 +1,48 @@
+# [Topic]: [Subtitle — e.g. "Current State of X" / "What's Changed Since Y"]
+
+*Compiled [Month Day, Year]*
+
+Based on [primary source, e.g. "the XYZ Report" or "recent reporting from..."], this summarizes [what the doc covers — one sentence scope statement].
+
+## The core idea
+
+[2-4 sentences giving the central framing or thesis. If there's a named concept, coin, or official framing from a primary source, bold it, e.g. **"Term Name"**. State who said it / where it comes from.]
+
+[Optional second paragraph: break the core idea into its main sub-components as a short list-in-prose, e.g. "In X, it does A. In Y, it does B. In Z, it does C."]
+
+[Optional: one sentence tying this to a specific event/announcement that prompted the compilation — a conference, report release, deal, etc.]
+
+## 1. [First major theme/angle]
+
+[1 sentence framing what this section covers.]
+
+- **[Entity/Company/Actor]** — [What they did, with concrete specifics: dollar amounts, dates, durations, capacities. One sentence, front-load the most important number/fact.]
+- **[Entity/Company/Actor]** — [Same pattern.]
+- **[Entity/Company/Actor]** — [Same pattern.]
+
+[Optional closing sentence with an aggregate figure or industry-tracker stat, clearly flagged as coming from "one industry tracker" or similar if unaudited.]
+
+**Counterpoint:** [1-2 sentences representing the strongest skeptical or critical take on this theme, attributed to a specific named source. Don't skip this if a credible counterpoint exists — it's what keeps the summary from reading as PR.]
+
+## 2. [Second major theme/angle]
+
+- **[Entity + specific initiative/product name]** — [What it does, who it's built with/partnered with, any concrete outcome metric.]
+- **[Entity + specific initiative/product name]** — [Same pattern.]
+- **[Entity + specific initiative/product name]** — [Same pattern.]
+
+## 3. [Third major theme/angle — e.g. institutional/regulatory angle]
+
+[Can be shorter — a paragraph instead of a bulleted list if there are fewer distinct items.]
+
+## A caveat
+
+[1-3 sentences of epistemic hygiene: note that the space is fast-moving, that figures are often industry-sourced rather than independently audited, and that claims should be read accordingly. This section is not optional — it's what separates a summary from stenography.]
+
+---
+
+## Sources
+
+1. [Publisher/Org — "Exact title of piece"](URL) — [optional one-line note, e.g. "original statement" or "critical coverage"]
+2. [Publisher/Org — "Exact title of piece"](URL)
+3. [Publisher/Org — "Exact title of piece"](URL)
+[... continue numbering every source actually used, in the order first cited or by rough importance]
\ No newline at end of file